Metabolic•FDA Approved

Semaglutide

Semaglutide is a GLP-1 receptor agonist that mimics the action of the human glucagon-like peptide-1 (GLP-1). It increases insulin secretion, decreases glucagon secretion, and slows gastric emptying.

Mechanism of Action

Acts on GLP-1 receptors in the brain to regulate appetite and food intake. It also enhances glucose-dependent insulin secretion from the pancreas.

Key Benefits

Significant weight loss
Improved blood sugar control
Reduced appetite and cravings
Cardiovascular benefits
Potential neuroprotective effects

Research Protocol

Loading Phase
0.25mg weekly for 4 weeks
Maintenance
Titrate up to 2.4mg weekly
Must be titrated slowly to avoid severe gastrointestinal side effects.

Chemical Properties

FormulaC187H291N45O59
Mol. Weight4113.58 g/mol

Side Effects & Risks

  • •Nausea
  • •Vomiting
  • •Diarrhea
  • •Constipation
  • •Fatigue

Amino Acid Sequence

Modified GLP-1 Analog (31 amino acids)
HomeLibraryResearchFavoritesToolsVisuals